Agenda Topics:

• Integrative and Collaborative Approaches to Redefine Drug Discovery
  • Industry-Institute/Biotech-Pharma Collaborations
• Structure/Target/Fragment based & Computational Approaches
  • 3D Structures, Interactive Docking, X-ray Structures
  • Fragment Library, Screening and Lead Identification
  • New Druggable Targets, Target Structure Elucidation
  • QSAR and Computational Approaches for Designing Molecules
• Techniques, Instruments, Screening Procedures & Enabling Technologies
  • 3D Printing, Microwave Synthesis, Flow Chemistry
  • Automated/Integrated Analytical, Synthesis & Screening Systems
  • Enantioselective/Chiral/Green Synthesis
  • Heterocyclic Chemistry, Catalysis
  • Lead Discovery Platforms and Strategies
  • Natural Products Chemistry – Identification and Characterization
  • Synthetic and Organic Medicinal Chemistry
• Traditional and Non-traditional Screening Approaches
  • Animal Models, Bioassays, Cell-based Assays, Pre-clinical Testing
  • Leveraging Big Data for Improving Discovery Rewards
  • Orphan Drugs, Drug Repurposing, Reverse Pharmacology
  • Pharmacological Activity of Novel Bioactive Molecules
  • Protein-DNA/RNA/Protein Interactions